ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 229 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2019. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $408,772 | +5.7% | 31,109 | +1.4% | 0.00% | 0.0% |
| Q2 2023 | $386,681 | -6.4% | 30,689 | -3.1% | 0.00% | -25.0% |
| Q1 2023 | $413,137 | -25.1% | 31,658 | +1.3% | 0.00% | -20.0% |
| Q4 2022 | $551,497 | +14.9% | 31,264 | -0.8% | 0.01% | 0.0% |
| Q3 2022 | $480,000 | +2.8% | 31,528 | +0.1% | 0.01% | 0.0% |
| Q2 2022 | $467,000 | -37.4% | 31,493 | -4.9% | 0.01% | -16.7% |
| Q1 2022 | $746,000 | +20.1% | 33,133 | -1.5% | 0.01% | +20.0% |
| Q4 2021 | $621,000 | +20.8% | 33,646 | -12.5% | 0.01% | +25.0% |
| Q3 2021 | $514,000 | -35.3% | 38,452 | -10.5% | 0.00% | -33.3% |
| Q2 2021 | $795,000 | +15.1% | 42,944 | -6.6% | 0.01% | 0.0% |
| Q1 2021 | $691,000 | +1.3% | 45,989 | -2.7% | 0.01% | 0.0% |
| Q4 2020 | $682,000 | +70.9% | 47,262 | -3.6% | 0.01% | +50.0% |
| Q3 2020 | $399,000 | +60.9% | 49,046 | +33.8% | 0.00% | +33.3% |
| Q2 2020 | $248,000 | -7.5% | 36,647 | -3.9% | 0.00% | -40.0% |
| Q1 2020 | $268,000 | -70.4% | 38,118 | -58.6% | 0.01% | -54.5% |
| Q4 2019 | $904,000 | -20.7% | 92,073 | -11.4% | 0.01% | -21.4% |
| Q3 2019 | $1,140,000 | -18.9% | 103,864 | -14.0% | 0.01% | -12.5% |
| Q2 2019 | $1,405,000 | +19.7% | 120,796 | -1.8% | 0.02% | +14.3% |
| Q1 2019 | $1,174,000 | -2.9% | 123,026 | -1.9% | 0.01% | -12.5% |
| Q4 2018 | $1,209,000 | -31.6% | 125,399 | +1.1% | 0.02% | -5.9% |
| Q3 2018 | $1,767,000 | +19.2% | 123,982 | +0.4% | 0.02% | +13.3% |
| Q2 2018 | $1,483,000 | -1.9% | 123,549 | +1.0% | 0.02% | 0.0% |
| Q1 2018 | $1,511,000 | -20.1% | 122,351 | -5.9% | 0.02% | -16.7% |
| Q4 2017 | $1,892,000 | +29.9% | 130,051 | +27.0% | 0.02% | +5.9% |
| Q3 2017 | $1,457,000 | +49.3% | 102,385 | +33.8% | 0.02% | +21.4% |
| Q2 2017 | $976,000 | +2.5% | 76,500 | +1.9% | 0.01% | +7.7% |
| Q1 2017 | $952,000 | +12.7% | 75,100 | -9.3% | 0.01% | +8.3% |
| Q4 2016 | $845,000 | -17.0% | 82,758 | +7.1% | 0.01% | -20.0% |
| Q3 2016 | $1,018,000 | +3.2% | 77,271 | -0.5% | 0.02% | +7.1% |
| Q2 2016 | $986,000 | -22.3% | 77,671 | -19.2% | 0.01% | -17.6% |
| Q1 2016 | $1,269,000 | -10.9% | 96,071 | +3.7% | 0.02% | -10.5% |
| Q4 2015 | $1,425,000 | +34.3% | 92,671 | +8.3% | 0.02% | +26.7% |
| Q3 2015 | $1,061,000 | -27.9% | 85,532 | -25.8% | 0.02% | -11.8% |
| Q4 2014 | $1,471,000 | +2.7% | 115,200 | +7.9% | 0.02% | -5.6% |
| Q3 2014 | $1,432,000 | -11.1% | 106,800 | +6.4% | 0.02% | -5.3% |
| Q2 2014 | $1,611,000 | -11.9% | 100,400 | -1.0% | 0.02% | -17.4% |
| Q1 2014 | $1,828,000 | +4.9% | 101,400 | -10.0% | 0.02% | +9.5% |
| Q4 2013 | $1,742,000 | -4.8% | 112,700 | -8.4% | 0.02% | -8.7% |
| Q3 2013 | $1,830,000 | +2.6% | 123,100 | -10.7% | 0.02% | -4.2% |
| Q2 2013 | $1,783,000 | +1.5% | 137,800 | +6.6% | 0.02% | -4.0% |
| Q1 2013 | $1,757,000 | – | 129,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |